Literature DB >> 2172006

Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy.

D A Engler1, G T Montelione, S K Niyogi.   

Abstract

Site-directed mutagenesis was employed to examine the function of two highly conserved residues, Tyr-37 and Arg-41, of human EGF (hEGF) in receptor binding. Both a conservative change to phenylalanine and a semi-conservative change to histidine at position 37 yield proteins with receptor affinity similar to wild-type hEGF. A non-conservative change to alanine results in a molecule with about 40% of the receptor affinity, indicating that an aromatic residue is not essential at this position. Both conservative (to lysine) and non-conservative (to alanine) substitutions at position 41 drastically reduced receptor binding to less than 0.5% of the wild-type activity. 1D-NMR data indicate that the replacement of Arg-41 by lysine does not significantly alter the native protein conformation. Thus, Arg-41 may be directly involved in ligand receptor interaction, whereas the side chain of Tyr-37, although possibly important structurally, is not essential for receptor binding.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172006     DOI: 10.1016/0014-5793(90)80368-s

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Structure-function studies of mEGF: probing the type I beta-turn between residues 25 and 26.

Authors:  C C Lester; B Wang; R Wu; H A Scheraga
Journal:  J Protein Chem       Date:  1995-11

2.  Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Authors:  Haeshin Lee; Tae Gwan Park
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

3.  N-terminal site-specific mono-PEGylation of epidermal growth factor.

Authors:  Haeshin Lee; Il Ho Jang; Sung Ho Ryu; Tae Gwan Park
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

4.  Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.

Authors:  D A Engler; M R Hauser; J S Cook; S K Niyogi
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation.

Authors:  J M Clements; L J Bawden; R E Bloxidge; G Catlin; A L Cook; S Craig; A H Drummond; R M Edwards; A Fallon; D R Green
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

6.  Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways.

Authors:  Dan Bao; Dan Lu; Ning Liu; Wei Dong; Ying-Dong Lu; Chuan Qin; Lian-Feng Zhang
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

7.  Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.

Authors:  K Nagata; D Kohda; H Hatanaka; S Ichikawa; S Matsuda; T Yamamoto; A Suzuki; F Inagaki
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

8.  Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain.

Authors:  Hannes H Loeffler; Martyn D Winn
Journal:  Proteins       Date:  2013-08-19

Review 9.  Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.

Authors:  Fiona Haxho; Ronald J Neufeld; Myron R Szewczuk
Journal:  Oncotarget       Date:  2016-06-28

10.  High precision protein functional site detection using 3D convolutional neural networks.

Authors:  Wen Torng; Russ B Altman
Journal:  Bioinformatics       Date:  2019-05-01       Impact factor: 6.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.